Where to Find the Cheapest Ingrezza Price

Our most recent US pharmacy data shows a low of roughly $8,462.83 for Ingrezza with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

Generic and brand-name pricing for Ingrezza is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

The out-of-pocket cost for Ingrezza with insurance depends entirely on the specifics of your health plan, including your deductible, copayment, and formulary tier. To obtain an accurate estimate, it is best to contact your insurance provider directly. For many patients, utilizing a pharmacy savings card in conjunction with insurance may further reduce the price paid at the pharmacy.

Ingrezza (valbenazine) is manufactured by Neurocrine Biosciences, Inc. As a branded medication, it is currently under patent protection, and a generic equivalent is not yet available.

Ingrezza (valbenazine) is a prescription medication approved to treat tardive dyskinesia (TD), a movement disorder characterized by involuntary, repetitive motions of the face and body. It belongs to a class of drugs called vesicular monoamine transporter 2 (VMAT2) inhibitors, which work by regulating certain brain chemicals involved in movement control. Before starting Ingrezza, it is important to inform your doctor of any history of heart conditions (such as long QT syndrome, heart failure, or heart attack), liver or kidney disease, or if you are pregnant, planning to become pregnant, or breastfeeding. The medication can cause drowsiness and affect coordination, so activities like driving should be approached with caution. Always take Ingrezza exactly as prescribed by your healthcare provider.